Cognex Corporation (NASDAQ:CGNX – Get Free Report) VP Laura Ann Macdonald sold 14,881 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $57.16, for a total value of $850,597.96. Following the completion of the sale, the vice president owned 2,212 shares in the company, valued at approximately $126,437.92. This represents a 87.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Cognex Trading Up 0.2%
CGNX stock traded up $0.12 during trading on Friday, hitting $58.79. The company had a trading volume of 4,790,845 shares, compared to its average volume of 2,239,616. The company has a fifty day moving average price of $39.03 and a two-hundred day moving average price of $41.31. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $59.88. The company has a market cap of $9.85 billion, a P/E ratio of 87.75 and a beta of 1.53.
Cognex (NASDAQ:CGNX – Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Cognex had a return on equity of 9.03% and a net margin of 11.51%.The company had revenue of $252.34 million during the quarter, compared to analysts’ expectations of $238.92 million. During the same period last year, the business earned $0.16 earnings per share. The business’s revenue was up 9.9% on a year-over-year basis. On average, analysts expect that Cognex Corporation will post 0.61 earnings per share for the current year.
Cognex Announces Dividend
Cognex News Roundup
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: Q4 results beat consensus: revenue of $252.3M (≈+9.9% y/y) and EPS that topped estimates; management raised Q1 EPS and gave revenue guidance above Street expectations — the core driver of today’s rally. Cognex Reports Fourth Quarter 2025 Results
- Positive Sentiment: Company highlights margin-focused portfolio optimization plus a shareholder-return push (dividend and buyback/upgrade messaging), which analysts and investors view as supportive of higher margins and multiple expansion. Why Cognex Is Up 48.6%
- Positive Sentiment: Analyst support: Needham raised its price target (and carries a Buy), and other outlets reported upgrades and target bumps following the quarter — amplifying buying interest. Benzinga — analyst coverage
- Positive Sentiment: Cash flow and balance-sheet strength were highlighted (operating cash jumped materially y/y; cash balances rose), giving the company flexibility to execute buybacks/dividends and sustain investment. QuiverQuant — Q4 summary and cash flow
- Neutral Sentiment: Full earnings-call transcripts and deep-dive coverage are available for investors who want management color on product mix, AI strategy and the margin plan; these provide detail but no new surprise beyond the release. Seeking Alpha — earnings call transcript
- Neutral Sentiment: Long-term performance pieces (e.g., 15‑year return stories) surfaced, useful for context but unlikely to move short-term price. Benzinga — long-term performance
- Negative Sentiment: Regulatory risk: Cognex disclosed rising AI-related regulatory and compliance risks that could increase costs, slow deployments or compress margins if global rules tighten — a longer-term headwind to watch. TipRanks — AI regulation risk
- Negative Sentiment: Insider activity and mixed analyst views: recent insider sales were reported and some firms still carry cautious targets/ratings — these can temper enthusiasm if repeated or if growth disappoints vs. elevated expectations. QuiverQuant — insider & analyst notes
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of CGNX. Stifel Financial Corp raised its stake in shares of Cognex by 0.7% during the fourth quarter. Stifel Financial Corp now owns 133,148 shares of the scientific and technical instruments company’s stock worth $4,791,000 after buying an additional 972 shares during the last quarter. Bank of Nova Scotia bought a new stake in shares of Cognex during the 4th quarter valued at $1,097,000. Morgan Stanley lifted its stake in shares of Cognex by 6.0% in the 4th quarter. Morgan Stanley now owns 1,517,130 shares of the scientific and technical instruments company’s stock valued at $54,586,000 after purchasing an additional 86,413 shares during the period. First Trust Advisors LP boosted its position in shares of Cognex by 32.3% in the 4th quarter. First Trust Advisors LP now owns 128,175 shares of the scientific and technical instruments company’s stock worth $4,612,000 after purchasing an additional 31,317 shares during the last quarter. Finally, Alyeska Investment Group L.P. bought a new position in shares of Cognex in the 4th quarter worth $68,388,000. Institutional investors own 88.12% of the company’s stock.
Wall Street Analyst Weigh In
CGNX has been the topic of several recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cognex in a report on Monday, December 29th. Robert W. Baird set a $45.00 target price on Cognex in a report on Friday, October 31st. DA Davidson set a $38.00 price target on Cognex and gave the company a “neutral” rating in a report on Monday, November 3rd. Barclays reiterated an “overweight” rating and set a $61.00 price target (up previously from $54.00) on shares of Cognex in a research report on Friday. Finally, Truist Financial lowered their price objective on shares of Cognex from $45.00 to $42.00 and set a “hold” rating for the company in a research report on Thursday, December 18th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Cognex presently has an average rating of “Moderate Buy” and an average price target of $50.73.
Get Our Latest Stock Analysis on CGNX
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Articles
- Five stocks we like better than Cognex
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
